← Eichor
Condition: Immunosuppression Synced from ClinicalTrials.gov · July 28, 2026

Recruiting studies: Immunosuppression

Studies currently listed as recruiting on the public registry for this search term. Each page explains the study in plain language, with locations and the study team's contact details. Clinicians: generate a printable list for your patient →

Early Signals of the Transition From Immune Quiescence to Activation in the Liver Allograft Microenvironment and in the
Phase 2 · 10 location(s) · National Institute of Allergy and Infectious Diseases (NIAID · NCT07549503Efficacy and Safety of High-dose Liposomal Amphotericin B for Disseminated Histoplasmosis in AIDS
Phase 3 · 5 location(s) · Federal University of Health Science of Porto Alegre · NCT05814432REgulatory T Cell Therapy to Achieve Immunosuppression REduction
Phase 2 · 7 location(s) · Singulera Therapeutics Inc. · NCT06552169Tacrolimus C:D Ratio Measured in Renal Transplant Recipients Treated With Once-daily Prolonged-release Drugs
Phase 4 · 9 location(s) · Edward Geissler · NCT06268769Evaluation of the Benefits of Administering Immunosuppressive Drugs as Single Daily Doses Over the First Year After Live
Phase 4 · 18 location(s) · University Hospital, Limoges · NCT06354179LAM-001 in Lung Transplant Recipients With Bronchiolitis Obliterans Syndrome.
Phase 2 · 1 location(s) · Steven Hays, MD · NCT06018766The Effect of Topical Imipramine on Photodynamic Therapy-Mediated Immunosuppression on Forearms or Face on US Veterans
Phase 2 · 1 location(s) · VA Office of Research and Development · NCT06778434InDuctIon TREatment with SubCuTaneous Infliximab for Crohn's Disease
Phase 3 · 1 location(s) · Academisch Medisch Centrum - Universiteit van Amsterdam (AMC · NCT06059989IS-free Treg HaploHCT
Phase 1 · 1 location(s) · Dana-Farber Cancer Institute · NCT04678401OveRcoming immunosupprEssion aNd rebAlancing the Immune reSponSe in ovAriaN CancEr Study
NA · 1 location(s) · Gynaecologisch Oncologisch Centrum Zuid · NCT06611072Viral Infection of HSPC Impacts Hematopoiesis
Phase N/A · 1 location(s) · Assistance Publique - Hôpitaux de Paris · NCT06458504Minimizing Glucocorticoid Administration in Patients With Proliferative Lupus Nephritis
Phase 4 · 1 location(s) · Institutul Clinic Fundeni · NCT05207358Cologne Cohort of Neutropenic Patients (CoCoNut)
Phase N/A · 1 location(s) · University Hospital of Cologne · NCT01821456Post Transplant Cyclophosphamide in Matched Unrelated Donor Stem Cell Transplantation for Hematological Malignancies
Phase 2/Phase 3 · 1 location(s) · Hospital Israelita Albert Einstein · NCT03818334Registry of Vaccine Responses in Immune Compromised Patients
Phase N/A · 1 location(s) · Laure Pittet, MD-PhD · NCT06463119Human Upper Extremity Allotransplantation: F/U Protocol
Phase N/A · 1 location(s) · Johns Hopkins University · NCT03400345Study of Progression of Community Acquired Pneumonia in the Hospital in Patients With More Severe Preexisting Diseases a
Phase N/A · 10 location(s) · Pneumonia Research Network on Genetic Resistance and Suscept · NCT05688774Human Upper Extremity Allotransplantation
Phase 2 · 1 location(s) · Johns Hopkins University · NCT01459107Tacrolimus Pharmacokinetic Subpopulations
Phase N/A · 2 location(s) · University Hospital, Grenoble · NCT04526431Role of Endomyocardial Biopsy and Aetiology-based Treatment in Patients With Inflammatory Heart Disease in Arrhythmic an
Phase N/A · 1 location(s) · Scientific Institute San Raffaele · NCT04521790Relationship Between Immunosuppressive Treatment Status and Clinical Course of Parkinson's Disease
Phase N/A · 1 location(s) · Medical University of Warsaw · NCT06834191This Study is Assessing the Safety and Efficacy of Immune Inhibition as a Treatment to Prevent Primary Graft Dysfunction
Phase 2 · 1 location(s) · University of California, San Francisco · NCT06853223Early Severe Illness TrAnslational BioLogy InformaticS in Humans
Phase N/A · 1 location(s) · London Health Sciences Centre Research Institute OR Lawson R · NCT05591924Safety and Immunogenicity of Recombinant Zoster Vaccine for Transplant Recipients
NA · 1 location(s) · Central Adelaide Local Health Network Incorporated · NCT06262776Immune Cells Role in Lung Cancer and Their Use in Anticancer Immunotherapies and Inflammatory Lung Disease
NA · 1 location(s) · Université Catholique de Louvain · NCT07384897Oral Bacteria and Immune System Problems Involved in Gum Disease (Periodontitis)
Phase N/A · 1 location(s) · National Institute of Dental and Craniofacial Research (NIDC · NCT01568697The OPTIMISE Study
Phase 4 · 8 location(s) · Maastricht University Medical Center · NCT05716945TTV-based mAnagement Of Long-term ImmunosuppreSsion in Kidney Transplantation
NA · 4 location(s) · Hospices Civils de Lyon · NCT06829719Tocilizumab in Lung Transplantation
Phase 2 · 21 location(s) · National Institute of Allergy and Infectious Diseases (NIAID · NCT06033196RFA Plus Carrizumab vs Carrizumab Alone for HCC
Phase 2 · 1 location(s) · Second Affiliated Hospital, School of Medicine, Zhejiang Uni · NCT04150744
Look up another condition
Patient organization or foundation? You can brand this page for your community — your logo, your resources, same honest registry data, kept current daily. Ask about branding →

This page is independently generated by Eichor from the public ClinicalTrials.gov record and re-synced daily. It is not the sponsor's official website unless claimed. Nothing here is medical advice; eligibility is always determined by the study team — talk to your own doctor first.